|
Real-time Estimate
Cboe BZX
20:31:52 13/11/2026 GMT
|
5-day change | 1st Jan Change | ||
| 959.24 USD | +0.85% |
|
+6.33% | +24.59% |
| Market Cap | 95.45B 86.5B 80B 72.18B 136B 9,000B 141B 961B 381B 4,808B 358B 351B 15,260B | P/E 2026 * |
16x | P/E 2027 * | 15.3x |
|---|---|---|---|---|---|
| Enterprise Value | 88.28B 80B 74B 66.76B 126B 8,324B 130B 889B 352B 4,446B 331B 324B 14,114B | EV / Sales 2026 * |
4.7x | EV / Sales 2027 * | 4.12x |
| Free-Float |
72.57% | Yield 2026 * |
0.4% | Yield 2027 * | 0.42% |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| REGN | Delayed | |
CBOE
| REGN | Real-time | |
|
Börse Stuttgart
| RGO | Delayed | |
|
Xetra
| RGO | End-of-day quote | |
|
Deutsche Boerse AG
| RGO | Delayed | |
|
Tradegate
| RGO | Real-time | |
|
Boerse Muenchen
| RGO | Real-time | |
|
London S.E.
| 0R2M | Delayed | |
|
Mexican S.E.
| REGN * | End-of-day quote | |
|
Borsa Italiana
| 1REGN | End-of-day quote | |
|
Wiener Boerse
| REGN | End-of-day quote | |
|
Lima
| REGNUS | End-of-day quote |
Last Transcript: Regeneron Pharmaceuticals, Inc.
| 1 day | +1.02% | ||
| 1 week | +6.05% | ||
| Current month | +3.36% | ||
| 1 month | +27.34% | ||
| 3 months | +18.99% | ||
| 6 months | +33.22% | ||
| Current year | +24.25% |
| 1 week | 898.29 |  | 981.55 |
| 1 month | 755.21 | | 991.73 |
| Current year | 591.52 | | 991.73 |
| 1 year | 591.52 | | 991.73 |
| 3 years | 476.49 | | 1,211.2 |
| 5 years | 476.49 | | 1,211.2 |
| 10 years | 271.37 | | 1,211.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
| President | 66 | 31/12/2000 | |
| Chief Executive Officer | 73 | 07/01/1988 | |
| Director of Finance/CFO | 55 | 04/02/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 73 | 08/06/2023 | |
Joseph Goldstein
BRD | Director/Board Member | 85 | 31/05/1991 |
George Sing
BRD | Director/Board Member | 76 | 07/01/1988 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 04/11/26 | Exercice | SVP Controller | 11,828 | 0.0117% | ||
| 03/11/26 | Exercice | Director | 22,317 | 0.0221% | ||
| 03/11/26 | Don | Chief Technology Officer | -1,054 | 0.0010% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.03% | +6.05% | +38.00% | +20.38% | 95.45B | |
| +1.48% | +6.89% | +41.50% | +136.21% | 1,271B | |
| +1.19% | +3.82% | +46.88% | +94.26% | 683B | |
| +0.43% | +1.55% | +27.35% | +113.37% | 520B | |
| -0.44% | +3.69% | +39.60% | +69.51% | 389B | |
| +0.60% | +0.50% | +58.68% | +43.91% | 362B | |
| -0.12% | +0.74% | +26.78% | +58.43% | 304B | |
| +0.37% | -0.43% | +3.43% | +38.57% | 286B | |
| -0.13% | +1.23% | +38.72% | +74.77% | 253B | |
| +0.32% | +0.83% | +34.40% | +124.58% | 208B | |
| Average | +0.49% | +2.12% | +35.53% | +77.40% | 437B | |
| Weighted average by Cap. | +0.74% | +2.75% | +37.82% | +94.93% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 18.78B 17.02B 15.74B 14.2B 26.77B 1,771B 27.71B 189B 74.99B 946B 70.49B 68.99B 3,003B | 20.15B 18.26B 16.89B 15.24B 28.72B 1,900B 29.73B 203B 80.45B 1,015B 75.62B 74.01B 3,222B |
| Net income | 6.43B 5.82B 5.39B 4.86B 9.16B 606B 9.48B 64.71B 25.66B 324B 24.12B 23.6B 1,027B | 6.56B 5.94B 5.5B 4.96B 9.35B 618B 9.68B 66.05B 26.19B 330B 24.62B 24.09B 1,049B |
| Net Debt | -7.17B -6.5B -6.01B -5.42B -10.22B -676B -10.58B -72.17B -28.62B -361B -26.9B -26.33B -1,146B | -12.52B -11.34B -10.49B -9.47B -17.84B -1,180B -18.47B -126B -49.98B -630B -46.97B -45.98B -2,001B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/11/26 | US$961.47 | +1.08% | 330,206 |
| 12/11/26 | US$951.19 | -0.86% | 1,211,308 |
| 11/11/26 | US$959.41 | +4.73% | 1,233,521 |
| 10/11/26 | US$916.06 | -0.42% | 517,079 |
| 09/11/26 | US$919.96 | +1.73% | 856,756 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- REGN Stock
Select your edition
All financial news and data tailored to specific country editions
